Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Qatar

Qatar

The Other Vaccines market in Qatar is expected to witness a significant growth in revenue, with projections indicating that it will reach US$21.07m in 2024.
This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 10.84%.
As a result, the market volume is projected to reach US$35.25m by 2029.
In comparison to other countries, United States is anticipated to generate the highest revenue in the market, with an estimated US$24,730.00m in 2024.
Qatar has seen a growing demand for other vaccines, with an increasing focus on preventative measures for diseases such as meningitis and pneumonia.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for Other Vaccines in Qatar has been increasing steadily in recent years.

Customer preferences: Customers in Qatar are increasingly aware of the importance of vaccination and are seeking out vaccines for a variety of illnesses. In addition to routine vaccinations, there has been a growing demand for travel vaccines as more Qataris are traveling abroad for business and leisure.

Trends in the market: The Other Vaccines market in Qatar is expected to continue to grow in the coming years due to several factors. Firstly, the government has been actively promoting vaccination programs and campaigns, which has increased awareness and demand for vaccines. Secondly, the growing population and increasing healthcare expenditure in Qatar is expected to drive demand for vaccines. Finally, the rising number of expatriates in Qatar is expected to increase demand for vaccines as many expatriates come from regions where certain diseases are more prevalent.

Local special circumstances: Qatar has a high standard of healthcare and a strong healthcare infrastructure, which has helped to increase demand for vaccines. The country has a well-established vaccination program, which includes routine vaccinations for children and adults. Additionally, Qatar has a high number of expatriates, which has led to a demand for vaccines that are not typically required in other countries.

Underlying macroeconomic factors: The Qatari economy has been growing steadily in recent years, which has led to an increase in healthcare expenditure. Additionally, the government has been investing heavily in healthcare infrastructure and promoting healthcare programs, which has helped to increase demand for vaccines. The country's high GDP per capita and relatively high standard of living have also contributed to the growth of the Other Vaccines market in Qatar.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.